Browse COVID-19 resources from partners and CCSA experts – trusted sources for your information and research needs.

Canadian Centre on Substance Use and Addiction

The information on COVID-19 and substance use in this section is organized by the types of audiences looking for information. These audiences include the pubic, service providers, people seeking services, people who use drugs, researchers and policy makers.

CCSA cannot vouch for the accuracy or currency of the information in these resources. Inclusion of a resource on this page does not imply endorsement or authorization by CCSA.

People in Pain

People in Pain

Resource Organization
Caring for patients with pain during the COVID-19 pandemic: consensus recommendations from an international expert panel Anaesthesia
COVID-19: Information Resources Canadian Arthritis Patient Alliance
EMCDDA trendspotter briefing - Impact of COVID-19 on drug services and help-seeking in Europe European Monitoring Centre for Drugs and Drug Addiction
Resources for Canadians living with pain during COVID-19 Government of Canada
COVID-19 news and resources for people living with pain Pain BC
Managing patients with chronic pain during the COVID-19 outbreak considerations for the rapid introduction of remotely supported (e-health) pain management services PAIN: The Journal of the International Association for the Study of Pain

 

People Seeking Services

People Seeking Services

Resource Organization
Editorial: Challenges to Opioid Use Disorders During COVID‐19 American Journal on Addictions
Virtual Addiction Counselling Canadian Addiction Counsellors Certification Federation
Virtual Care for Mental Health and Substance Use During COVID-19 [infographic] Canadian Centre on Substance Use and Addiction, Canadian Psychological Association, Canadian Society of Addiction Medicine, Mental Health Commission of Canada, The Royal
Wellness Together Canada: Mental Health and Substance Use Support Government of Canada
Provincial/Territorial Class Exemptions for Supervised Consumption Site Operators Health Canada
COVID-19 Crisis: Harm Reduction Resources for People who Use Drugs  INPUD (International Network of People who Use Drugs)
COVID-19 During the Opioid Epidemic - Exacerbation of Stigma and Vulnerabilities Journal of Rural Health
COVID-19: Potential Implications for Individuals with Substance Use Disorders National Institute on Substance Abuse
There’s Life Beyond Addiction SMART Recovery
Online Resources for Substance use Disorders during COVID-19 Thunderbird Partnership Foundation
Coronavirus and Drug Harm Reduction  Transform
Suggestions about treatment, care and rehabilitation of people with drug use disorder in the context of the COVID-19 pandemic United Nations Office on Drugs and Crime
Support and resources for women Women For Sobriety
COVID-19 (in French only) Institut universitaire sur les dépendances et Centre intégré universitaire de santé et de services sociaux du Centre-Sud-de-l'Île-de-Montréal

 

People Who Use Drugs

People Who Use Drugs

Resource Organization
Mental Wellness Moment — Managing cravings during COVID-19 (video) Alberta Health Services
Mental Wellness Moment — Making healthy choices about substance use (video) Alberta Health Services
Mental Wellness Moment — Cannabis safety during COVID-19 (video) Alberta Health Services
Options for meeting online Alcoholics Anonymous
Cannabis use and COVID-19 Assembly of First Nations
COVID-19: Harm Reduction and Overdose Response  B.C. Centre for Disease Control
People who use substances  B.C. Centre for Disease Control
Substance Use and COVID-19 B.C. Centre on Substance Use
Statement from BCCSU on COVID-19 B.C. Centre on Substance Use
Virtual Addiction Counselling Canadian Addiction Counsellors Certification Federation
Impacts of the COVID-19 Pandemic on People Who Use Substances: What We Heard Canadian Centre on Substance Use and Addiction
Methamphetamine, the Respiratory System and COVID-19 [report] Canadian Centre on Substance Use and Addiction
Methamphetamine, Cocaine and COVID-19 Health Risks [infographic] Canadian Centre on Substance Use and Addiction
COVID-19 and Impaired Driving Risks (infographic) Canadian Centre on Substance Use and Addiction
Getting Back on the Road: Relaxing of COVID-19 Measures and Impaired Driving Risks (infographic) Canadian Centre on Substance Use and Addiction
COVID-19 and Cannabis Smoking and Vaping: Four Things You Should Know (report) Canadian Centre on Substance Use and Addiction
COVID-19 and Cannabis Smoking: 4 Things You Should Know (infographic) Canadian Centre on Substance Use and Addiction
COVID-19 and Cannabis: How to Reduce Your Risk (infographic) Canadian Centre on Substance Use and Addiction
COVID-19, Alcohol and Cannabis Use (infographic) Canadian Centre on Substance Use and Addiction
COVID 19, Alcohol and Cannabis Use (report) Canadian Centre on Substance Use and Addiction
Virtual Care for Mental Health and Substance Use During COVID-19 [infographic] Canadian Centre on Substance Use and Addiction, Canadian Psychological Association, Canadian Society of Addiction Medicine, Mental Health Commission of Canada, The Royal
Cannabinoids and the Coronavirus Cannabis and Cannabinoid Research
People with substance use disorders face greater challenges during the COVID-19 pandemic The Conversation
Coronavirus – General Hygiene Harm Reduction Tips Crew
COVID-19 Safer Drug Use Harm Reduction Tips Eastern Health / Opioid Dependance Treatment Centre of Excellence
COVID-19 and people who use drugs European Monitoring Centre for Drugs and Drug Addiction
Cannabis and COVID-19 First Nations Health Authority
Substance Use – Harm Reduction and COVID-19 First Nations Health Authority
Caring for Pregnant and Parenting Women with OUD During the COVID-19 Pandemic (slides from webinar) Foundation for Opioid Response Efforts
Wellness Together Canada: Mental Health and Substance Use Support Government of Canada
COVID-19 Safer Drug Use Harm Reduction Tips Government of Newfoundland and Labrador
Substance Use During the Pandemic Government of Newfoundland and Labrador
COVID-19: Stimulant Use, and Harm Reduction Harm Reduction Coalition
COVID-19 Guidance for People Who Use Drugs and Harm Reduction Programs  Harm Reduction Coalition
Recovering from addiction during a time of uncertainty and social distancing Harvard Health Publishing
COVID-19 Crisis: Harm Reduction Resources for People who Use Drugs  INPUD (International Network of People who Use Drugs)
In the time of COVID-19: Civil society statement on COVID-19 and people who use drugs International Drug Policy Consortium
Coronavirus disease (COVID-19): Resources and information International Drug Policy Consortium (IDPC)
Cannabis in the Time of Coronavirus Disease 2019: The Yin and Yang of the Endocannabinoid System in Immunocompetence The Journal of Alternative and Complementary Medicine
COVID-19 During the Opioid Epidemic - Exacerbation of Stigma and Vulnerabilities Journal of Rural Health
COVID-19 Harm Reduction Tips for People Who Use Drugs Manitoba Harm Reduction Network
FAQs on COVID-19 and Addiction/Substance Use Disorder National Institute on Drug Abuse, U.S.
COVID-19 Harm Reduction COVID-19: Stay Home, Stay Safe New Zealand Drug Foundation
Helpful information on substance use during the COVID-19 pandemic Office of the Chief Medical Officer of Health, Government of New Brunswick
Statement by the UN expert on the right to health on the protection of people who use drugs during the COVID-19 pandemic Office of the High Commissioner of Human Rights, United Nations
COVID-19 Guidance: Consumption and Treatment Services (CTS) Sites  Ontario Ministry of Health
Avoiding a new epidemic during a pandemic: The importance of assessing the risk of substance use disorders in the COVID-19 era Psychiatry Research
COVID-19, Stimulant Use, and Harm Reduction Resolve to Save Lives and Vital Strategies
People with a dependency a hidden cost of lockdown Royal Australian College of General Practitioners
Managing Withdrawal during COVID-19 Thunderbird Partnership Foundation
Harm reduction during COVID-19 Thunderbird Partnership Foundation
Online Resources for Substance use Disorders during COVID-19 Thunderbird Partnership Foundation
COVID-19 Harm Reduction Tips  Toronto Public Health
Coronavirus and Drug Harm Reduction Transform
UNSW Speakeasy Podcast, S05, Extra Easy Ep 1: COVID-19 & Harm Reduction Special University of New South Wales
Safer Use Strategies to Reduce Risk of COVID-19 Transmission   Vancouver Costal Health
Guidance for People Who Use Substances on COVID-19   Yale Program in Addiction Medicine, Global Health Justice Partnership, and Crackdown
A Message for Young People Who Use Drugs Youth Rise
Pour un usage de substances à moindre risque dans le cadre de la pandémie de COVID-19 (in French only) Association des intervenants en dépendance du Québec
Ressources pour les usagers (in French only) Centre intégré universitaire de santé et de services sociaux du Centre-Sud-de-l'Île-de-Montréal
COVID-19 (in French only) Institut universitaire sur les dépendances et Centre intégré universitaire de santé et de services sociaux du Centre-Sud-de-l'Île-de-Montréal

 

Policymakers

Policymakers

Resource Organization
Mitigating and learning from the impact of COVID‐19 infection on addictive disorders Addiction
Rapid Implementation of Service Delivery Changes to Mitigate COVID-19 and Maintain Access to Methadone Among Persons with and at High-Risk for HIV in an Opioid Treatment Program AIDS and Behavior
Editorial: Challenges to Opioid Use Disorders During COVID-19 American Journal of Addictions
When Epidemics Collide: Coronavirus Disease 2019 (COVID-19) and the Opioid Crisis Annals of Internal Medicine
An Epidemic in the Midst of a Pandemic: Opioid Use Disorder and COVID-19 Annals of Internal Medicine
Collision of the COVID-19 and Addiction Epidemics Annals of Internal Medicine
COVID-19 pandemic and addiction: Current problems and future concerns Asian Journal of Psychiatry
Risk Mitigation in the Context of Dual Public Health Emergencies B.C. Centre on Substance Use
Impacts of the COVID-19 Pandemic on People Who Use Substances: What We Heard Canadian Centre on Substance Use and Addiction
Open versus Closed: The Risks Associated with Retail Liquor Stores during COVID-19 Canadian Centre on Substance Use and Addiction
COVID-19 Harm Reduction Resources  Canadian Drug Policy Coalition
Don't forget our dual public health crises Canadian Journal of Emergency Medicine
Is another public health crisis brewing beneath the COVID-19 pandemic? Canadian Journal of Public Health
Substance Use Prevention During the COVID-19 Pandemic Carnevale Associates
People Who Use Drugs Are Experiencing Overlapping Crises During COVID-19 CMAJ
Sharing Experiences (prepared by partners and members) Correlation – European Harm Reduction Network
COVID-19 and addiction Diabetes & Metabolic Syndrome: Clinical Research & Reviews
Alcohol use in times of the COVID 19: Implications for monitoring and policy Drug and Alcohol Review
EMCDDA Trendspotter briefing: impact of COVID-19 on patterns of drug use and drug-related harms in Europe European Monitoring Centre for Drugs and Drug Addiction
EMCDDA special report: COVID-19 and drugs – Drug supply via darknet markets European Monitoring Centre for Drugs and Drug Addiction
COVID-19 and people who use drugs European Monitoring Centre for Drugs and Drug Addiction
Challenges of methadone maintenance treatment during the COVID-19 epidemic in China: policy and service recommendation European Neuropsychopharmacology
EMCDDA trendspotter briefing - Impact of COVID-19 on drug services and help-seeking in Europe European Monitoring Centre for Drugs and Drug Addiction
COVID-19 and the drug supply chain: from production and trafficking to use (UNODC) European Monitoring Centre for Drugs and Drug Addiction
EMCDDA special report: COVID-19 and drugs – Drug supply via darknet markets European Monitoring Centre for Drugs and Drug Addiction
EU Drug Markets — Impact of COVID-19 European Monitoring Centre for Drugs and Drug Addiction
Global Drug Survey, Special Edition on COVID-19 Global Drug Survey
Syringe Services and Harm Reduction Provider Operations During the COVID-19 Outbreak Harm Reduction Coalition
Challenges in maintaining treatment services for people who use drugs during the COVID-19 pandemic Harm Reduction Journal
A tale of two epidemics: When COVID-19 and opioid addiction collide Harvard Health Publishing
Exceptional importation & sale of drugs in relation to COVID-19: Tier 3 drug shortages Health Canada
In the time of COVID-19: Civil society statement on COVID-19 and people who use drugs International Drug Policy Consortium
First ISAM Webinar on COVID-19 and Drug Addiction, March 23, 2020  International Society of Addiction Medicine
COVID‐19 During the Opioid Epidemic – Exacerbation of Stigma and Vulnerabilities Journal of Rural Health
A Primary Care Response to COVID‐19 for Patients with an Opioid Use Disorder Journal of Rural Health
Alcohol use and misuse during the COVID-19 pandemic: a potential public health crisis? The Lancet
Drinking alone: COVID-19, lockdown, and alcohol-related harm The Lancet Gastroenterology & Hepatology
COVID-19: Suggested Health Department Actions to Support Syringe Services Programs (SSPs) NASTAD
Avoiding a new epidemic during a pandemic: The importance of assessing the risk of substance use disorders in the COVID-19 era Psychiatry Research
COVID19 pandemic and people with opioid use disorder: innovation to reduce risk Psychiatry Research
COVID19: Opioid Risk Mitigation Research-to-Policy Collaboration
Avoiding a new epidemic during a pandemic: The importance of assessing the risk of substance use disorders in the COVID-19 era Psychiatry Research
Updated guidance for contingency planning for services during COVID-19 published  Scottish Drugs Forum
Survey: Impacts of COVID-19 on Canadians Statistics Canada
Canadians who report lower self-perceived mental health during the COVID-19 pandemic more likely to report increased use of cannabis, alcohol and tobacco Statistics Canada
Opioid use disorder and the COVID 19 pandemic: A call to sustain regulatory easements and further expand access to treatment Substance Abuse
Rights in the time of COVID-19: Lessons from HIV for an effective, community-led response UNAIDS
COVID-19 and the drug supply chain: from production and trafficking to use United Nations Office on Drugs and Crime

 

Public

Public

Resource Organization
Problem Gambling in the Time of COVID-19 (webinar) Addictions Foundation of Manitoba
Editorial: Challenges to Opioid Use Disorders During COVID‐19 American Journal on Addictions
Cannabis use and COVID-19 Assembly of First Nations
Mental Wellness and COVID-19: Tips and Considerations Assembly of First Nations
Tobacco Use and COVID-19 Assembly of First Nations
Novel coronavirus (COVID-19) information for patients with chronic health conditions  B.C. Centre for Disease Control
Substance Use and COVID-19 B.C. Centre on Substance Use
Statement from BCCSU on COVID-19 B.C. Centre on Substance Use
Tips for supporting your mental health through the COVID-19 pandemic  B.C. Mental Health and Substance Use Services
Managing COVID-19 Stress, Anxiety and Depression B.C. Ministry of Mental Health and Addictions
Caring for Others with Addiction During a Time of Uncertainty and Social Distancing Cambridge Health Alliance
Statement: Prevention of Fetal Alcohol Spectrum Disorder (FASD) during the COVID-19 pandemic Canada FASD Research Network
Virtual Addiction Counselling Canadian Addiction Counsellors Certification Federation
Supporting Harm Reduction in COVID 19 Shelter and Self Isolation (webinar) Canadian Alliance to End Homelessness
COVID-19: Information Resources Canadian Arthritis Patient Alliance
Virtual Care for Mental Health and Substance Use During COVID-19 [infographic] Canadian Centre on Substance Use and Addiction, Canadian Psychological Association, Canadian Society of Addiction Medicine, Mental Health Commission of Canada, The Royal
Coping with Stress, Anxiety, and Substance Use During Covid-19: How Animals Can Help [infographic] Canadian Centre on Substance Use and Addiction
Methamphetamine, Cocaine and COVID-19 Health Risks [infographic] Canadian Centre on Substance Use and Addiction
COVID-19 and Impaired Driving Risks (infographic) Canadian Centre on Substance Use and Addiction
Getting Back on the Road: Relaxing of COVID-19 Measures and Impaired Driving Risks (infographic) Canadian Centre on Substance Use and Addiction
Open versus Closed: The Risks Associated with Retail Liquor Stores during COVID-19 Canadian Centre on Substance Use and Addiction
COVID-19 and Cannabis Smoking: 4 Things You Should Know (infographic) Canadian Centre on Substance Use and Addiction
COVID-19 and Cannabis: How to Reduce Your Risk (infographic) Canadian Centre on Substance Use and Addiction
COVID-19 and Increased Alcohol Consumption: NANOS Poll Summary Report Canadian Centre on Substance Use and Addiction
COVID-19, Alcohol and Cannabis Use (infographic) Canadian Centre on Substance Use and Addiction
COVID 19, Alcohol and Cannabis Use (report) Canadian Centre on Substance Use and Addiction
Coping with Stress, Anxiety, and Substance Use During COVID-19 [infographic] Canadian Centre on Substance Use and Addiction and Mental Health Commission of Canada
COVID-19 and mental health and well-being  Canadian Mental Health Association
COVID, youth, and substance use: Critical messages for youth and families Canadian Paedriatric Society
CAMH: Mental Health and the COVID-19 Pandemic Centre for Addiction and Mental Health (CAMH)
People with substance use disorders face greater challenges during the COVID-19 pandemic The Conversation
Alcohol and Self-Isolation: What Are Quebecers Doing? Éduc'alcool
Isolation and alcohol during a pandemic Éduc'alcool
Alcohol Use: Risk Mitigation Strategies During a Pandemic First Nations Health Authority
Resources for Safer Gambling During COVID-19 Gambling Research Exchange Ontario
COVID-19 mobile app Government of Canada
Taking care of your mental health (COVID-19) Government of Canada
Wellness Together Canada: Mental Health and Substance Use Support Government of Canada
COVID-19: Mental Health and Wellness Government of Newfoundland and Labrador
Substance Use During the Pandemic Government of Newfoundland and Labrador
A tale of two epidemics: When COVID-19 and opioid addiction collide Harvard Health Publishing
In the time of COVID-19: Civil society statement on COVID-19 and people who use drugs International Drug Policy Consortium
FAQs on COVID-19 and Addiction/Substance Use Disorder National Institute on Drug Abuse, U.S.
COVID-19 Harm Reduction COVID-19: Stay Home, Stay Safe New Zealand Drug Foundation
Statement by the UN expert on the right to health on the protection of people who use drugs during the COVID-19 pandemic Office of the High Commissioner of Human Rights, United Nations
The Emerging Impact of COVID-19 on Gambling in Ontario Responsible Gambling Council
Canadians report lower self-perceived mental health during the COVID-19 pandemic Statistics Canada
Survey: Impacts of COVID-19 on Canadians Statistics Canada
Harm reduction during COVID-19 Thunderbird Partnership Foundation
Managing Withdrawal during COVID-19 Thunderbird Partnership Foundation
Online Resources for Substance use Disorders during COVID-19 Thunderbird Partnership Foundation
More tips for managing Safe Alcohol Use during COVID-19 Thunderbird Partnership Foundation
Managing Safe Alcohol Use During COVID-19 Thunderbird Partnership Foundation
Rights in the time of COVID-19: Lessons from HIV for an effective, community-led response UNAIDS
Paws Your Stress Therapy Dog Program University of Saskatechewan
Alcohol and COVID-19: what you need to know World Health Organization, Europe

 

Researchers

Researchers

Resource Organization
Methamphetamine, the Respiratory System and COVID-19 [report] Canadian Centre on Substance Use and Addiction
COVID-19 and Cannabis Smoking and Vaping: Four Things You Should Know [report] Canadian Centre on Substance Use and Addiction
Open versus Closed: The Risks Associated with Retail Liquor Stores during COVID-19 Canadian Centre on Substance Use and Addiction
COVID-19 and Increased Alcohol Consumption: NANOS Poll Summary Report Canadian Centre on Substance Use and Addiction
EMCDDA trendspotter briefing - Impact of COVID-19 on drug services and help-seeking in Europe European Monitoring Centre for Drugs and Drug Addiction
COVID-19 and the drug supply chain: from production and trafficking to use (UNODC) European Monitoring Centre for Drugs and Drug Addiction
Global Drug Survey, Special Edition on COVID-19 Global Drug Survey
First ISAM Webinar on COVID-19 and Drug Addiction, March 23, 2020  International Society of Addiction Medicine
COVID-19 Resource Centre  The Lancet
COVID-19: Potential Implications for Individuals with Substance Use Disorders  National Institute on Drug Abuse (NIDA)
Synopsis of Key Articles – Coronavirus Disease 2019 (COVID-19) Public Health Ontario
Survey: Impacts of COVID-19 on Canadians Statistics Canada
Canadians who report lower self-perceived mental health during the COVID-19 pandemic more likely to report increased use of cannabis, alcohol and tobacco Statistics Canada
COVID-19 and the drug supply chain: from production and trafficking to use United Nations Office on Drugs and Crime

 

Service Providers

Service Providers

Resource Organization
Supporting Access to Alcohol Use Disorder and Alcohol Withdrawal Treatment American Association of Addiction Medicine
Editorial: Challenges to Opioid Use Disorders During COVID‐19 American Journal on Addictions
Managing mental health during COVID-19 American Medical Association
COVID-19 - Infection Mitigation in Outpatient Settings American Society of Addiction Medicine
COVID-19 - Infection Mitigation in Residential Treatment Facilities American Society of Addiction Medicine
COVID-19 - Supporting Access to Buprenorphine American Society of Addiction Medicine
COVID-19 - Supporting Access to Telehealth American Society of Addiction Medicine
Recommendations on Chronic Pain Practice during the COVID-19 Pandemic  American Society of Regional Anesthesia & Pain Medicine (ASRA)
COVID-19 pandemic and addiction: Current problems and future concerns Asian Journal of Psychiatry
Overdose in the context of COVID-19 outbreak BCCDC Harm Reduction Services
COVID-19: Harm Reduction and Overdose Response  B.C.Centre for Disease Control
COVID-19: Information for Opioid Agonist Treatment Prescribers and Pharmacists  B.C. Centre on Substance Use
Risk Mitigation in the Context of Dual Public Health Emergencies B.C. Centre on Substance Use
COVID-19: Responding to Opioid Overdoses in Overdose Prevention Services (OPS) and Supervised Consumption Sites (SCS) BC Ministry of Health
COVID-19 National Emergency Response California Bridge
Immediately reduce person to person contact in MAT services California Bridge
Starting Buprenorphine Outside of Hospitals/Clinics California Bridge
Virtual Addiction Counselling Canadian Addiction Counsellors Certification Federation
Supporting Harm Reduction in COVID 19 Shelter and Self Isolation (webinar) Canadian Alliance to End Homelessness
Virtual Care for Mental Health and Substance Use During COVID-19 [infographic] Canadian Centre on Substance Use and Addiction, Canadian Psychological Association, Canadian Society of Addiction Medicine, Mental Health Commission of Canada, The Royal
Methamphetamine, the Respiratory System and COVID-19 [report] Canadian Centre on Substance Use and Addiction
Methamphetamine, Cocaine and COVID-19 Health Risks [infographic] Canadian Centre on Substance Use and Addiction
COVID-19 and Impaired Driving Risks (infographic) Canadian Centre on Substance Use and Addiction
Getting Back on the Road: Relaxing of COVID-19 Measures and Impaired Driving Risks (infographic) Canadian Centre on Substance Use and Addiction
COVID-19 and Cannabis Smoking and Vaping: Four Things You Should Know [report] Canadian Centre on Substance Use and Addiction
COVID-19 and Cannabis Smoking: 4 Things You Should Know [infographic] Canadian Centre on Substance Use and Addiction
COVID-19 and Cannabis: How to Reduce Your Risk [infographic] Canadian Centre on Substance Use and Addiction
Managing Stress, Anxiety and Substance Use During Covid-19: A Resource for Healthcare Providers [infographic] Canadian Centre on Substance Use and Addiction and Mental Health Commission of Canada
COVID-19 Pandemic — National Rapid Guidance Canadian Research Initiative in Substance Misuse
Supporting people who use substances in shelter settings during the COVID‑19 pandemic Canadian Research Initiative on Substance Misuse
Telemedicine support for addiction services Canadian Research Initiative on Substance Misuse
COVID-19 - Opioid Agonist Treatment Guidance  Canadian Society of Addiction Medicine
Ensuring Our Own Wellbeing as We Care for Others During the COVID-19 Crisis Canadian Society of Physician Leaders
COVID -19: Opioid Agonist Treatment Guidance Centre for Addiction and Mental Health
Sharing Experiences (prepared by partners and members) Correlation – European Harm Reduction Network
COVID-19 and people who use drugs European Monitoring Centre for Drugs and Drug Addiction
Cannabis and COVID-19 First Nations Health Authority
Alcohol Use: Risk Mitigation Strategies During a Pandemic First Nations Health Authority
Substance Use – Harm Reduction and COVID-19 First Nations Health Authority
OUD & the Emergency Department Experience During the COVID-19 Pandemic (video) Foundation for Opioid Response Efforts
Creating an Effective Telehealth Patient Experience for MOUD During the COVID-19 Pandemic (webinar) Foundation for Opioid Response Efforts
MOUD and the COVID-19 National Emergency Response (webinar) Foundation for Opioid Response Efforts
Caring for Pregnant and Parenting Women with OUD During the COVID-19 Pandemic (slides from webinar) Foundation for Opioid Response Efforts
Resources for Safer Gambling During COVID-19 Gambling Research Exchange Ontario
COVID-19 – Supporting People Requiring Opioid Dependence Treatment (ODT)  Government of Newfoundland and Labrador
Syringe Services and Harm Reduction Provider Operations During the COVID-19 Outbreak Harm Reduction Coalition
COVID-19 Guidance for People Who Use Drugs and Harm Reduction Programs  Harm Reduction Coalition
Challenges in maintaining treatment services for people who use drugs during the COVID-19 pandemic Harm Reduction Journal
CDSA Exemption and Interpretive Guide for Controlled Substances Health Canada
Exceptional importation & sale of drugs in relation to COVID-19: Tier 3 drug shortages Health Canada
Frequently Asked Questions: Subsection 56(1) Class Exemption for Patients, Practitioners and Pharmacists Prescribing and Providing Controlled Substances in Canada during the Coronavirus Pandemic Health Canada
Provincial/Territorial Class Exemptions for Supervised Consumption Site Operators Health Canada
Subsection 56(1) class exemption for patients, practitioners and pharmacists prescribing and providing controlled substances in Canada during the coronavirus pandemic Health Canada
Overdose Safety and Support During the Coronavirus Outbreak Homeless Services Association of B.C.
In the time of COVID-19: Civil society statement on COVID-19 and people who use drugs International Drug Policy Consortium
Supporting Frontline and Mental Health and Addiction Staff in the Covid-19 Environment International Initiative for Mental Health Leadership and International Initiative for Disability Leadership
COVID-19: Suggested Health Department Actions to Support Syringe Services Programs (SSPs) NASTAD
Clinical guide for the management of people with alcohol dependence during the coronavirus pandemic National Health Service, England
COVID-19 Harm Reduction COVID-19: Stay Home, Stay Safe New Zealand Drug Foundation
Statement by the UN expert on the right to health on the protection of people who use drugs during the COVID-19 pandemic Office of the High Commissioner of Human Rights, United Nations
COVID-19 and Opioid Treatment Programs Ohio Mental Health and Addiction Services
Managing patients with chronic pain during the COVID-19 outbreak considerations for the rapid introduction of remotely supported (e-health) pain management services PAIN: The Journal of the International Association for the Study of Pain
COVID-19: guidance for commissioners and providers of services for people who use drugs or alcohol Public Health England and Department of Health and Social Care
COVID19: Opioid Risk Mitigation Research-to-Policy Collaboration
Updated guidance for contingency planning for services during COVID-19 published Scottish Drugs Forum
Considerations for Crisis Centers and Clinicians in Managing the Treatment of Alcohol or Benzodiazepine Withdrawal during the COVID-19 Epidemic: March 19, 2020 Substance Abuse and Mental Health Services Administration
OTP Guidance for Patients Quarantined at Home with the Coronavirus Substance Abuse and Mental Health Services Administration
Suggestions about treatment, care and rehabilitation of people with drug use disorder in the context of the COVID-19 pandemic United Nations Office on Drugs and Crime
COVID-19 HIV Prevention, Treatment, Care and Support for People Who Use Drugs and People in Prison   United Nations Office on Drugs and Crime
Suggestions about treatment, care and rehabilitation of people with drug use disorder in the context of the COVID-19 pandemic United Nations Office on Drugs and Crime
Alcohol and Opioid use in the Time of COVID-19 (webinar summary and link) University of British Columbia
UNSW Speakeasy Podcast, S05, Extra Easy Ep 1: COVID-19 & Harm Reduction Special University of New South Wales
A public health approach to withdrawal management in a pandemic Vancouver Coastal Health
Prescriber Guidelines for Risk Mitigation in the Context of Dual Public Health Emergencies Vancouver Coastal Health
Coronavirus (COVID-19): guidance for substance misuse and homelessness services (version 1) Welsh Government
Harm Reduction Guidance  Yale Program in Addiction Medicine
COVID-19 et les approches favorisant l’observance des mesures de précaution et de protection auprès des personnes en situation de vulnérabilité (in French only) Institut national d'excellence en santé et en services sociaux
Le traitement du trouble lié à l’utilisation d'opioïdes (TUO) : version temporaire comprenant les mesures d'exception autorisées par Santé Canada en lien avec al pandémie de la COVID-19 (in french only) Collège des médecins du Québec
COVID-19 (coronavirus) (in French only) Institut national de santé publique du Québec
COVID-19 (in French only) Institut universitaire sur les dépendances et Centre intégré universitaire de santé et de services sociaux du Centre-Sud-de-l'Île-de-Montréal

 

We use cookies to ensure that we give you the best experience possible on our website. 

You can change your cookie settings in your web browser at any time. If you continue without changing your settings, we’ll assume that you are happy to receive cookies from our website. Review our Privacy Notice for more information.